C0014587||Episomal
C0243095||Nonviral
C1517498||Gene Therapy Vectors
C1854494||Slow Progression
C0004153||Atherosclerosis
C0020445||Familial Hypercholesterolemia
C0020445||Familial hypercholesterolemia
C0020445||Familial hypercholesterolemia
C2826244||life-threatening
C0019247||genetic disorder
C1278149||levels of plasma low-density lipoprotein cholesterol
C0023824||LDL-cholesterol
C0017296||gene therapy
C0020445||Familial hypercholesterolemia
C0035902||promoters
C3272453||genomic DNA
C0017262||expression
C0017397||mini-gene vector
C0017262||expressing
C0086418||human
C1366529||LDLR
C0006556||cDNA
C0086418||human
C1366529||LDLR
C0678933||locus
C3272453||genomic DNA
C0035902||promoter
C1101610||miRNA
C1415615||3-hydroxy-3-methylgutaryl-coenzyme A reductase
C1415615||3-hydroxy-3-methylgutaryl-coenzyme A reductase
C1366529||LDLR
C0017262||expression
C0017397||vector
C0038855||suppresses
C1415615||3-hydroxy-3-methylgutaryl-coenzyme A reductase
C1519595||transcripts
C1515655||in vivo
C1366529||LDLR
C0282641||transgene
C0017262||expression
C1366529||Ldlr(-/-)
C0206745||mouse model
C0020445||Familial hypercholesterolemia
C1533734||administration
C0017397||vector
C1278073||atherogenic plasma lipids
C0017397||episomal nonviral vectors
C0004153||atherosclerosis
C1515655||in vivo
C0017397||vector
C0596286||cellular regulation
C1366529||LDLR
C0017262||expression
C1366529||LDLR
C2350567||knockdown
C1415615||3-hydroxy-3-methylgutaryl-coenzyme A reductase
C0017296||gene therapy
C0443264||modulate
C0178719||intracellular
C0008377||cholesterol
C0360714||statins
C0087111||therapeutic application
C0020445||Familial hypercholesterolemia